Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies

[Image: see text] Novel drug development is a time-consuming process with relatively high debilitating costs. To overcome this problem, computational drug repositioning approaches are being used to predict the possible therapeutic scaffolds against different diseases. In the current study, computati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Mubashir, Yasir, Muhammad, Shahzadi, Saba, Kloczkowski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202290/
https://www.ncbi.nlm.nih.gov/pubmed/35721972
http://dx.doi.org/10.1021/acsomega.2c00518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202290/
https://www.ncbi.nlm.nih.gov/pubmed/35721972
http://dx.doi.org/10.1021/acsomega.2c00518

Ejemplares similares